ag 1879 has been researched along with Cognitive Dysfunction in 1 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, DZ | 1 |
| Waldau, B | 1 |
| Ander, BP | 1 |
| Zhan, X | 1 |
| Stamova, B | 1 |
| Jickling, GC | 1 |
| Lyeth, BG | 1 |
| Sharp, FR | 1 |
1 other study available for ag 1879 and Cognitive Dysfunction
| Article | Year |
|---|---|
Inhibition of Src family kinases improves cognitive function after intraventricular hemorrhage or intraventricular thrombin.
Topics: Animals; Cerebral Ventricles; Cognitive Dysfunction; Disease Models, Animal; Enzyme Inhibitors; Fema | 2017 |